Skip to content

REDPOINT BIO CORP: 10-K filed 2012-04-16

What REDPOINT BIO CORP reported in its annual report filed 2012-04-16 (fiscal FY 2011): 26 published measures, 112 facts as tagged in accession 0001144204-12-021993.

This filing

Form
10-K (annual report)
Filed
2012-04-16
Fiscal period
fiscal FY 2011
Accession
0001144204-12-021993 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All REDPOINT BIO CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-12-31137,156USD
At 2010-12-311,791,994USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-12-31469,263USD
At 2010-12-311,899,241USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-31-332,107USD
At 2010-12-31-107,247USD
At 2009-12-314,778,466USD
At 2008-12-3112,926,715USD
At 2007-12-3121,538,775USD
At 2006-12-31-20,725,857USD
At 2005-12-31-14,010,163USD
At 2004-12-31-8,544,076USD
At 2003-12-31-3,297,213USD
At 2002-12-31-721,741USD
At 2001-12-31141,600USD
At 2000-12-3125,468USD
At 1999-12-31-17,759USD
At 1998-12-3155,746USD
At 1997-12-31-58,039USD
At 1996-12-31-9,854USD
At 1995-12-31-2,785USD
At 1995-08-150USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-12-31126,724USD
At 2010-12-311,082,999USD
At 2009-12-315,557,367USD
At 2008-12-313,130,561USD
At 1995-08-150USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-440,241USD365
1995-08-16 to 2011-12-31-53,830,477USD5982
2010-01-01 to 2010-12-31-5,469,823USD365
2009-01-01 to 2009-12-31-8,816,012USD365
2008-01-01 to 2008-12-31-9,521,059USD366
2007-01-01 to 2007-12-31-10,476,387USD365
2006-01-01 to 2006-12-31-6,852,139USD365
2005-01-01 to 2005-12-31-4,367,326USD365
2004-01-01 to 2004-12-31-4,803,026USD366
2003-01-01 to 2003-12-31-2,360,483USD365
2002-01-01 to 2002-12-31-864,319USD365
2001-01-01 to 2001-12-31116,192USD365
2000-01-01 to 2000-12-3142,905USD366
1999-01-01 to 1999-12-31-73,505USD365
1998-01-01 to 1998-12-31113,785USD365
1997-01-01 to 1997-12-31-48,185USD365
1996-01-01 to 1996-12-31-7,069USD366
1995-08-16 to 1995-12-31-3,785USD138

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-12-310USD365
1995-08-16 to 2011-12-313,380,219USD5982
2010-01-01 to 2010-12-310USD365
2009-01-01 to 2009-12-3113,939USD365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-410,726USD365
1995-08-16 to 2011-12-31-1,498,010USD5982
2010-01-01 to 2010-12-31-101,306USD365
2009-01-01 to 2009-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-12-310USD
At 2010-12-31337,297USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-12-31208,797USD365
1995-08-16 to 2011-12-314,934,510USD5982
2010-01-01 to 2010-12-31583,536USD365
2009-01-01 to 2009-12-31680,893USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-2,433,260USD365
1995-08-16 to 2011-12-31-54,775,556USD5982
2010-01-01 to 2010-12-31-5,441,411USD365
2009-01-01 to 2009-12-31-8,722,821USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-31137,156USD
At 2010-12-311,155,199USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-01-01 to 2011-12-3134,781USD365
1995-08-16 to 2011-12-313,841,656USD5982
2010-01-01 to 2010-12-31140,751USD365
2009-01-01 to 2009-12-31235,231USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-31469,263USD
At 2010-12-311,547,499USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-12-31372,904USD
At 2010-12-31954,275USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2011-01-01 to 2011-12-310USD365
1995-08-16 to 2011-12-31283,121USD5982
2010-01-01 to 2010-12-310USD365
2009-01-01 to 2009-12-310USD365

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-01-01 to 2011-12-312,958,260USD365
1995-08-16 to 2011-12-3168,875,037USD5982
2010-01-01 to 2010-12-316,685,890USD365
2009-01-01 to 2009-12-3110,591,249USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,021,173USD365
1995-08-16 to 2011-12-3138,130,920USD5982
2010-01-01 to 2010-12-313,041,684USD365
2009-01-01 to 2009-12-315,630,336USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-3179,914,879shares
At 2010-12-3179,846,893shares

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-12-310USD
At 2010-12-31299,498USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-12-3143,500USD
At 2010-12-31171,124USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-12-3110,432USD
At 2010-12-3172,200USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-850,967USD365
1995-08-16 to 2011-12-31-55,328,487USD5982
2010-01-01 to 2010-12-31-5,571,129USD365
2009-01-01 to 2009-12-31-8,816,012USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2009-01-01 to 2009-12-31-8,880,566USD365
2008-01-01 to 2008-12-31-9,498,216USD366
2007-01-01 to 2007-12-31-10,434,676USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,937,087USD365
1995-08-16 to 2011-12-3130,744,117USD5982
2010-01-01 to 2010-12-313,644,206USD365
2009-01-01 to 2009-12-314,960,913USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-310USD365
1995-08-16 to 2011-12-310USD5982
2010-01-01 to 2010-12-310USD365
2009-01-01 to 2009-12-31-139,095USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31214,262USD365
1995-08-16 to 2011-12-311,476,993USD5982
2010-01-01 to 2010-12-31295,714USD365
2009-01-01 to 2009-12-31-210,994USD365

Inspect the source

Entity
REDPOINT BIO CORP / CIK 0001328003
Captured
SEC response SHA-256
ecfc5d113443b9a026d38a0778b52ff2b0efdd07d9400844ef023d75edf90e9b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001328003.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))